2016 US Venture Capital Investment into Life Sciences Companies: An Analysis by Evolution Global

In order to elucidate the focus of Venture Capital funding in the Biotechnology sector this year, Evolution Analysts have assessed the deals carried out by the Top 25 US Venture

Share